Rapamycin-induced phosphaturia (Q43109214)

14 November 2017

Rapamycin-induced phosphaturia (English)

1 reference

14 November 2017

Daniela S Kempe

1

1 reference

14 November 2017

Miribane Dërmaku-Sopjani

2

1 reference

14 November 2017

Henning Fröhlich

3

1 reference

14 November 2017

Mentor Sopjani

4

1 reference

14 November 2017

Anja Umbach

5

1 reference

14 November 2017

Goverdhan Puchchakayala

6

1 reference

14 November 2017

Anna Capasso

7

1 reference

14 November 2017

Florian Weiss

8

1 reference

14 November 2017

Michael Stübs

9

1 reference

14 November 2017

Michael Föller

10

1 reference

14 November 2017

Florian Lang

11

1 reference

14 November 2017

language of work or name

English

0 references

publication date

5 April 2010

1 reference

Nephrology Dialysis Transplantation

14 November 2017

1 reference

14 November 2017

25

1 reference

14 November 2017

9

1 reference

14 November 2017

2938-2944

1 reference

Rapamycin and mTOR kinase inhibitors

14 November 2017

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ172

mTOR regulates memory CD8 T-cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ172

mTOR: taking cues from the immune microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ172

Targeting the phosphoinositide 3-kinase pathway in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ172

Targeting the PI3K/AKT/mTOR signaling network in acute myelogenous leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ172

GOLPH3 modulates mTOR signalling and rapamycin sensitivity in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ172

Enhancing mTOR-targeted cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ172

Reducing the risk of left ventricular hypertrophy in kidney transplant recipients: the potential role of mammalian target of rapamycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ172

Autosomal dominant polycystic kidney disease: time for a change?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ172

Activation of the AKT/mTOR pathway in autosomal recessive polycystic kidney disease (ARPKD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ172

Long-term rapamycin therapy in the Han:SPRD rat model of polycystic kidney disease (PKD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ172

mTOR: dissecting regulation and mechanism of action to understand human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ172

Amino acids and mTOR signalling in anabolic function

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ172

The expanding TOR signaling network

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ172

Effect of leptin on liver alcohol dehydrogenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ172

Cell size reduction induced by inhibition of the mTOR/S6K-signaling pathway protects Jurkat cells from apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ172

Control of the hypoxic response through regulation of mRNA translation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ172

mTOR complex 2 (mTORC2) controls hydrophobic motif phosphorylation and activation of serum- and glucocorticoid-induced protein kinase 1 (SGK1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ172

(Patho)physiological significance of the serum- and glucocorticoid-inducible kinase isoforms

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ172

Stimulation of the intestinal phosphate transporter SLC34A2 by the protein kinase mTOR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ172

Impaired phosphate handling of renal allografts is aggravated under rapamycin-based immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ172

Mechanisms of vascular calcification

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ172

Vascular calcification: pathobiological mechanisms and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ172

Sodium-dependent phosphate cotransporters and vascular calcification

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ172

Mutation of the mouse klotho gene leads to a syndrome resembling ageing

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ172

The Klotho gene family and the endocrine fibroblast growth factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ172

Phosphatonins and the regulation of phosphate homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ172

Proximal tubular handling of phosphate: A molecular perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ172

Regulation of phosphate transport in proximal tubules.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ172

The sodium phosphate cotransporter family SLC34

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ172

The Na+-Pi cotransporter PiT-2 (SLC20A2) is expressed in the apical membrane of rat renal proximal tubules and regulated by dietary Pi

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ172

Insulinlike growth factor I and the kidney.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ172

Regulation and physiological roles of serum- and glucocorticoid-induced protein kinase isoforms

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ172

Comparison of potent Kv1.5 potassium channel inhibitors reveals the molecular basis for blocking kinetics and binding mode.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ172

Modulation of the voltage-gated potassium channel Kv1.5 by the SGK1 protein kinase involves inhibition of channel ubiquitination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ172

The peptide transporter PEPT2 is targeted by the protein kinase SGK1 and the scaffold protein NHERF2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ172

Blunted apoptosis of erythrocytes from taurine transporter deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ172

Renal Fanconi syndrome and myopathy after liver transplantation: drug-related mitochondrial cytopathy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ172

Tubular toxicity in sirolimus- and cyclosporine-based transplant immunosuppression strategies: an ancillary study from a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ172

Dietary and serum phosphorus regulate fibroblast growth factor 23 expression and 1,25-dihydroxyvitamin D metabolism in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ172

Genetic mutation in the human 25-hydroxyvitamin D3 1alpha-hydroxylase gene causes vitamin D-dependent rickets type I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ172

Role of the vitamin D receptor in FGF23 action on phosphate metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ172

FGF23-mediated regulation of systemic phosphate homeostasis: is Klotho an essential player?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ172

Differential effects of 19-nor-1,25-dihydroxyvitamin D(2) and 1,25-dihydroxyvitamin D(3) on intestinal calcium and phosphate transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ172

Effect of high phosphate concentration on osteoclast differentiation as well as bone-resorbing activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ172

21 January 2018

Identifiers

DOI

10.1093/NDT/GFQ172

1 reference

14 November 2017

1 reference